CA2167282A1 - Apoptose avec regulation - Google Patents
Apoptose avec regulationInfo
- Publication number
- CA2167282A1 CA2167282A1 CA002167282A CA2167282A CA2167282A1 CA 2167282 A1 CA2167282 A1 CA 2167282A1 CA 002167282 A CA002167282 A CA 002167282A CA 2167282 A CA2167282 A CA 2167282A CA 2167282 A1 CA2167282 A1 CA 2167282A1
- Authority
- CA
- Canada
- Prior art keywords
- ligand
- binding
- cells
- domain
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
- C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
Abstract
On a développé un processus général de dimérisation ou d'oligomérisation régulée (pouvant être induite) de protéines intracellulaires. Des procédés et des substances sont décrites, lesquels permettent d'amorcer de manière régulable l'apoptose (mort cellulaire programmée) dans des cellules produites par technique génétique.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9349993A | 1993-07-16 | 1993-07-16 | |
US08/093,499 | 1993-07-16 | ||
US17914394A | 1994-01-07 | 1994-01-07 | |
US08/179,143 | 1994-01-07 | ||
PCT/US1994/001617 WO1994018317A1 (fr) | 1993-02-12 | 1994-02-14 | Transcription regulee de genes cibles et d'autres evenements biologiques |
WOPCT/US94/01617 | 1994-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2167282A1 true CA2167282A1 (fr) | 1995-01-26 |
Family
ID=27377531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002167282A Abandoned CA2167282A1 (fr) | 1993-07-16 | 1994-07-18 | Apoptose avec regulation |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPH09503645A (fr) |
AU (1) | AU696991B2 (fr) |
CA (1) | CA2167282A1 (fr) |
FI (1) | FI960165A (fr) |
HU (1) | HUT73100A (fr) |
WO (1) | WO1995002684A1 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4470226B2 (ja) * | 1994-08-18 | 2010-06-02 | アリアド・ファーマシューティカルズ・インコーポレイテッド | 新規な多量体化剤 |
WO1996012796A1 (fr) * | 1994-10-25 | 1996-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Transformation de l'etat de cellules produites par genie genetique |
WO1996041865A1 (fr) * | 1995-06-07 | 1996-12-27 | Ariad Gene Therapeutics, Inc. | Regulation d'evenements biologiques fondee sur la rapamycine |
US6187757B1 (en) | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
EP0907750B1 (fr) * | 1996-04-26 | 2002-09-18 | Massachusetts Institute Of Technology | Methode de criblage a l'aide de trois hybrides |
JPH10234372A (ja) * | 1997-02-27 | 1998-09-08 | Boehringer Mannheim Corp | キメラ受容体を有する細胞とその作成方法、並びに その利用 |
AU6692298A (en) * | 1997-03-07 | 1998-09-22 | Ariad Gene Therapeutics, Inc. | New applications of gene therapy technology |
US6274602B1 (en) | 1998-06-03 | 2001-08-14 | Gpi Nil Holdings, Inc. | Heterocyclic thioester and ketone hair growth compositions and uses |
US6187796B1 (en) | 1998-06-03 | 2001-02-13 | Gpi Nil Holdings, Inc. | Sulfone hair growth compositions and uses |
US6187784B1 (en) | 1998-06-03 | 2001-02-13 | Gpi Nil Holdings, Inc. | Pipecolic acid derivative hair growth compositions and uses |
US6271244B1 (en) | 1998-06-03 | 2001-08-07 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses |
US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
PT1016714E (pt) | 1997-06-27 | 2003-09-30 | Ono Pharmaceutical Co | Novo adn plasmidico que compreende adn do gene reporter e sua utilizacao |
US6982082B1 (en) | 1997-08-27 | 2006-01-03 | President And Fellows Of Harvard College | Gene therapy by cell specific targeting |
US6153383A (en) * | 1997-12-09 | 2000-11-28 | Verdine; Gregory L. | Synthetic transcriptional modulators and uses thereof |
FR2774289B1 (fr) * | 1998-02-03 | 2002-05-24 | Goemar Lab Sa | Medicament pour le traitement des dereglements de l'apoptose |
US6984635B1 (en) | 1998-02-13 | 2006-01-10 | Board Of Trustees Of The Leland Stanford Jr. University | Dimerizing agents, their production and use |
AU3454799A (en) * | 1998-03-30 | 1999-10-18 | Baylor College Of Medicine | Regulated apoptosis using chemically induced dimerization of apoptosis factors |
CA2330611A1 (fr) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Molecules bifonctionnelles et therapies basees sur celles-ci |
JP2002516843A (ja) | 1998-06-03 | 2002-06-11 | ジー・ピー・アイ ニイル ホールディングス インコーポレィティッド | ヘテロサイクリックエステルおよびアミド発毛組成物およびその使用 |
US6172087B1 (en) | 1998-06-03 | 2001-01-09 | Gpi Nil Holding, Inc. | N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses |
DK1115862T3 (da) * | 1998-09-23 | 2009-11-16 | Zymogenetics Inc | Cytokinreceptor Zalpha11 |
GB9914650D0 (en) * | 1999-06-24 | 1999-08-25 | Angyogene Pharmaceuticals Ltd | Chimeric proteins mediating targeted apoptosis |
GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
EP1229924A4 (fr) | 1999-11-19 | 2004-12-15 | Univ Leland Stanford Junior | Molecules bifonctionnelles ciblees et therapies basees sur celles-ci |
US7220552B1 (en) | 1999-11-19 | 2007-05-22 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and their use in the disruption of protein-protein interactions |
US6887842B1 (en) | 1999-11-19 | 2005-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug |
JP4963142B2 (ja) | 2000-12-14 | 2012-06-27 | 学校法人慶應義塾 | 遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法 |
CN100522967C (zh) | 2002-02-01 | 2009-08-05 | 阿里亚德基因治疗公司 | 含磷化合物及其应用 |
US7638331B2 (en) | 2004-01-02 | 2009-12-29 | The Administration of the Tulane Rducation Fund | Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery |
US7968762B2 (en) | 2004-07-13 | 2011-06-28 | Van Andel Research Institute | Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF) |
JP2009528545A (ja) | 2006-03-02 | 2009-08-06 | ザ ユーエービー リサーチ ファウンデーション | マイコバクテリウム属の疾患検出、処置、および薬物開発 |
EP2258858A1 (fr) | 2009-06-05 | 2010-12-08 | Universitätsklinikum Freiburg | Modèle animal pour le cancer transgénique pour LSD1 |
US10634668B2 (en) | 2012-09-13 | 2020-04-28 | Takara Bio Usa, Inc. | Modifiable chemical inducers of proximity and methods of using the same |
EP3008192B1 (fr) | 2013-06-11 | 2019-07-17 | Takara Bio USA, Inc. | Microvésicules enrichies en protéines et leurs procédés de fabrication et d'utilisation |
EP3443001A4 (fr) | 2016-04-11 | 2020-04-29 | Obsidian Therapeutics, Inc. | Systèmes de biocircuits régulés |
US10828330B2 (en) | 2017-02-22 | 2020-11-10 | IO Bioscience, Inc. | Nucleic acid constructs comprising gene editing multi-sites and uses thereof |
WO2021079656A1 (fr) * | 2019-10-24 | 2021-04-29 | 国立大学法人千葉大学 | Procédé de mesure de l'activité d'une enzyme de métabolisation de lipides dans une cellule, et substance destinée à être utilisée dans la mesure de l'activité d'une enzyme de métabolisation de lipides dans une cellule |
CN116179608B (zh) * | 2023-01-05 | 2024-03-01 | 昆明理工大学 | 一种dsRNA在免疫缺陷中华蜜蜂模型构建中的应用 |
-
1994
- 1994-07-18 HU HU9600083A patent/HUT73100A/hu unknown
- 1994-07-18 CA CA002167282A patent/CA2167282A1/fr not_active Abandoned
- 1994-07-18 WO PCT/US1994/008008 patent/WO1995002684A1/fr not_active Application Discontinuation
- 1994-07-18 JP JP7504752A patent/JPH09503645A/ja active Pending
- 1994-07-18 AU AU73363/94A patent/AU696991B2/en not_active Expired
-
1996
- 1996-01-15 FI FI960165A patent/FI960165A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
AU696991B2 (en) | 1998-09-24 |
FI960165A (fi) | 1996-01-26 |
JPH09503645A (ja) | 1997-04-15 |
HUT73100A (en) | 1996-06-28 |
WO1995002684A1 (fr) | 1995-01-26 |
AU7336394A (en) | 1995-02-13 |
HU9600083D0 (en) | 1996-03-28 |
FI960165A0 (fi) | 1996-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2167282A1 (fr) | Apoptose avec regulation | |
CA2155728C (fr) | Transcription regulee de genes cibles et d'autres evenements biologiques | |
US6054436A (en) | Regulated apoptosis | |
US5830462A (en) | Regulated transcription of targeted genes and other biological events | |
US6140120A (en) | Regulated transcription of targeted genes and other biological events | |
US5869337A (en) | Regulated transcription of targeted genes and other biological events | |
US6972193B1 (en) | Regulated transcription of targeted genes and other biological events | |
US8084596B2 (en) | Regulated apoptosis | |
KR19990022651A (ko) | 생물학적 사건에 대한 라파마이신 기재 조절방법 | |
JP2002508971A (ja) | 多量体キメラ蛋白質を使用する生物学的イベントの調節 | |
EP0776335A1 (fr) | Elimination modulable d'expression genique, de fonction de produit genique, et de cellules hotes obtenues par genie genetique | |
AU690898C (en) | Regulated transcription of targeted genes and other biological events | |
EP0776359A1 (fr) | Apoptose regulee | |
JP2002514893A (ja) | 生物学的事象のラパマイシンに基づく調節 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20080821 |